Trials / Completed
CompletedNCT07154212
Hepatitis B Virus Reactivation in COVID-19
Managing the Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Treated With Corticosteroids
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,793 (actual)
- Sponsor
- University Medical Centre Ljubljana · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this observational cohort study was to evaluate adherence to hepatitis B virus (HBV) screening guidelines in a country characterized by low HBV prevalence and assess the potential reactivation and progression of HBV infection in anti-HBV core antigen antibodies (anti-HBc) positive patients receiving corticosteroids for coronavirus disease 2019 (COVID-19).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Hepatitis B virus infection | anti-hepatitis B virus core antigen positive serologic status |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2022-04-08
- Completion
- 2022-04-08
- First posted
- 2025-09-04
- Last updated
- 2025-09-04
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT07154212. Inclusion in this directory is not an endorsement.